WallStreetZenWallStreetZen

NASDAQ: AMPH
Amphastar Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Amphastar Pharmaceuticals revenue was $731.97M for the trailing 12 months ending Dec 31, 2024, with 15.4% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $186.5M, down 2.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AMPH annual revenue was $732.0M, with 13.6% growth year-over-year.

AMPH past revenue growth

How has AMPH's revenue growth performed historically?

Company
13.59%
Industry
10.09%
Market
20.27%
AMPH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AMPH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AMPH's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AMPH revenue history

Current Revenue
$732.0M
Current Earnings
$159.5M
Current Profit Margin
21.8%

Be the first to know when AMPH announces revenue.

AMPH Revenue History By Year

AMPH Yearly RevenueAMPH RevenueAMPH ChangeAMPH Revenue Growth
2024-12-31$731.97M$87.57M+13.59%
2023-12-31$644.40M$145.41M+29.14%
2022-12-31$498.99M$61.22M+13.98%
2021-12-31$437.77M$87.92M+25.13%
2020-12-31$349.85M$27.49M+8.53%
2019-12-31$322.36M$27.69M+9.40%
2018-12-31$294.67M$54.49M+22.69%
2017-12-31$240.18M-$14.99M-5.87%
2016-12-31$255.17M$3.65M+1.45%
2015-12-31$251.52M$41.06M+19.51%
2014-12-31$210.46M-$19.22M-8.37%
2013-12-31$229.68M$25.36M+12.41%
2012-12-31$204.32M$85.97M+72.63%
2011-12-31$118.36MN/AN/A

1 of 1

Amphastar Pharmaceuticals Revenue FAQ

What was AMPH's revenue last quarter?

On Invalid Date, Amphastar Pharmaceuticals (NASDAQ: AMPH) reported Q4 2024 revenue of $186.52 million up 4.73% year over year. In the same quarter last year, Amphastar Pharmaceuticals's revenue was $178.11 million.

What was Amphastar Pharmaceuticals's revenue in 2024?

Amphastar Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $731.97 million, a 13.59% increase year over year.

How much does Amphastar Pharmaceuticals make in a day?

Based on Amphastar Pharmaceuticals annual revenue for the past five years, AMPH makes an average of $1,459,157.81 per day.

What was Amphastar Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Amphastar Pharmaceuticals's revenue has grown 13.59% year over year. This is 3.5 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.09%. Amphastar Pharmaceuticals's revenue in the past year totaled $731.97 million.

How much does Amphastar Pharmaceuticals make in a year?

Amphastar Pharmaceuticals's revenue by year for the past five years is:
  • Amphastar Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $731.97 million, a 13.59% increase year over year.
  • Amphastar Pharmaceuticals's annual revenue for Dec 31, 2023 was $644.40 million, a 29.14% increase from 2022.
  • Amphastar Pharmaceuticals's annual revenue for 2022 was $498.99 million, a 13.98% increase from 2021.
  • Amphastar Pharmaceuticals's annual revenue for 2021 was $437.77 million, a 25.13% increase from 2020.
  • Amphastar Pharmaceuticals's annual revenue for 2020 was $349.85 million, a 8.53% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.